Lessons From the Discovery of Leptin: is Obesity an Endocrine Disease?

References

• Stunkard AJ. Current views on obesity Am J Med 1996; 100:230–6.
   Google Scholar
• Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond B Biol Sci. 1953; 140: 578–92.
   Google Scholar
• Hcrvey GR, Duggan JP. The concept of feedback control of body fat content and the evidence for it. Int Monograph on Nutr Me tab and Obesity. 1990; 1:1–18.
   Google Scholar
• Weigle DS. Appetite and the regulation of body composition. FASEB (Fed Am Soc Ex Biol) J. 1994; 8: 302–10.
   Google Scholar
• Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425–32.
   Google Scholar
• McGarry JD. Does leptin lighten the problem of obesity? Cur Biol. 1995; 5: 1342–44.
   Google Scholar
• Cusin I, Sainsbury A, Doyle P. Rohner-Jeanrenaud F. Jeanrenaud B. The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes. 1995; 44: 1467–70.
   Google Scholar
• Lindpainter K. Finding an obesity gene: a tale of mice and man. N Engl J Med. 1995; 332: 679–80.
   Google Scholar
• Rohner-Jeanrenaud F, Jeanrenaud B. Obesity, leptin, and the brain. N Engl J Med. 1996; 334:324–5.
   Google Scholar
• Berry F.M, Schneider BS. The ob gene product. A long term satiety signal? Nutr Metab Cardiovasc Dis. 1996; 6: 3–5.
   Google Scholar
• Ltinnqvist F. The obese (ob) gene and its product leptin-a new route toward obesity treatment in man? Q J Med. 1996; 89: 327–32.
   Google Scholar
• Wurtman RJ. What is leptin for, and docs it act on the brain? Nature Med. 1996; 2: 492–3.
   Google Scholar
• Bray GA. Leptin and leptinomania. Lancet. 1996; 348: 140–1.
   Google Scholar
• Keesey RE, Powley TL. The regulation of body weight. Annu Rev Psychol. 1986; 37: 109–33.
   Google Scholar
• Bouchard C, PtSrusse L. Genetics of obesity. Ann Rev Nutr. 1993; 13: 337–54.
   Google Scholar
• Ingalls AM, Dickie MM, Snell GD. Obese, new mutation in house mouse. J Hered. 1950; 41: 3178.
   Google Scholar
• Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia. 1978; 14: 141–8.
   Google Scholar
• Friedman JM, Lcibel RD, Siegel DS, Walsh J, Bahary N. Molecular mapping of the mouse ob mutation. Genomics. 1991; 11: 1054–62.
   Google Scholar
• Halaas JL, Gajiwala KS, Maffei M, et al. Weight reducing effects of the plasma protein encoded by the obese gene. Science. 1995; 269: 543–6.
   Google Scholar
• Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995; 269: 5403.
   Google Scholar
• Campfield LA, Smith FJ, Guise/. Y, Devos R, Burn P. Recombinant mouse leptin: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995; 269: 546–9.
   Google Scholar
• Weigle DS, Bukowski TR, Foster DC, et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest. 1995; 96: 2065–70.
   Google Scholar
• Levin N, Nelson C, Gurney A, Vandlen R, de Sauvage F. Decreased food intake docs not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci USA. 1996; 93: 1726–30.
   Google Scholar
• Stephens TW, Basinski M, Brislow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995; 377: 530–2.
   Google Scholar
• Bray GA. The nutrient balance hypothesis: peptides, sympathetic activity, and food intake. Ann NY Acad Sci. 1993; 676: 223–41.
   Google Scholar
• Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet. 1996; 12: 318–20.
   Google Scholar
• Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995; 83: 1263–71.
   Google Scholar
• Devos R. Richards JG, Campfield LA et al. OB protein binds specifically to the choroid plexus in mice and rats. Proc Natl Acad Sci USA. 1996; 93: 5668–73.
   Google Scholar
• Banks WA, Kastin AJ, Huang WT, Jaspan JD, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides. 1996; 17: 305–11.
   Google Scholar
• Lee G-H, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996; 379: 632–5.
   Google Scholar
• Chua SC Jr. Chung WK, Wu-Peng S et al, Phcnotypes of mouse diabetes and rat falty due to mutations in the OB (leptin) receptor. Science. 1996; 271: 994–6.
   Google Scholar
• Frcderich RC, Lollmann B, Hamann A, et al. Expression of ob mRNA and its encoded protein in rodents: impact of nutrition and obesity. J Clin Invest. 1995; 96: 1658–63.
   Google Scholar
• Maffei M, Halaas J. Ravussin E, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects.Mature Med. 1995; 1: 1155–61.
   Google Scholar
• Saladin R, De Vos P, Guerre-Millo M, et al. Transient increase in obese gene expression after food intake or insulin administration. Nature. 1995; 377: 527–9.
   Google Scholar
• De Vos P, Saladin R, Auwerx J, Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem. 1995; 270: 15958–61.
   Google Scholar
• Zimmet P, Alberti KGMM. Leptin: is it important in diabetes? Diabetic Med. 1996; 13:501–3.
   Google Scholar
• Maffei M, Stoffel M, Barone M, et al. Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes. 1996; 45: 679–82.
   Google Scholar
• Niki T, Mori H, Tamori Y et al. Human obese gene. Molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes. 1996; 45: 675–8.
   Google Scholar
• Clement K, Garner C, Hager J, et al. Indication for linkage of the human OB gene region with extreme obesity. Diabetes. 1996; 45: 687–90.
   Google Scholar
• Reed DR, Ding Y, Xu W, Calher C, Green ED, Price RA. Extreme obesity may be linked to markers flanking the human OB gene. Diabetes. 1996; 45:691–4.
   Google Scholar
• Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292–5.
   Google Scholar
• Lonnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med. 1995; 1:950–3.
   Google Scholar
• Hamilton BS, Paglia D, Kwan AYM, Deitel M Increased obese mRNA expression in omental fa cells from massively obese humans. Nature Med. 1995; 1:953–6.
   Google Scholar
• Considine RV, Considine EL, Williams CJ, et al. Evidence against either a premature stop codon oi the absence of obese gene mRNA in human obesity. J Clin Invest. 1995; 95: 2986–88.
   Google Scholar
• Masuzaki H, Ogawa Y, Isse N et al. Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes. 1995; 44: 855–8.
   Google Scholar
• Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF. The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes. 1996; 19: 992–6.
   Google Scholar
• Schwartz M W, Peskind E, Raskind M, Boyko EJ, Porte D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Med. 1996; 2: 587–93.
   Google Scholar
• Caro JF, Kolaczynski J W, Nyce MR, et al. Decreased cerebrospinal-fiuid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet. 1996; 348: 159–61.
   Google Scholar
• Scheen AJ, Paquot N, Letiexhe M, Paolisso G, Castillo MJ, LeRibvre PJ. Glucose metabolism in obese subjects: lessons from OGTT, IVGTT, and clamp studies, hit J Obesity. 1995; 19, Suppl. 3: S14–S20.
   Google Scholar
• Scheen AJ, Leffcbvre PJ. Pathophysiology of Type 2 diabetes. In: Handbook of Experimental Pharmacology, Oral Antidiabetics (J. Kuhlmann and W. Puis, Eds), Springer, Berlin, 1995, pp. 7–42.
   Google Scholar
• Scheen AJ, Desaive C, Leffcbvre PJ. Therapy for obesity-today and tomorrow. Bailliere’s Clin Endocrinol Metab. 1994; 8: 705–27.
   Google Scholar